PE20110305A1 - Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y un nsaid - Google Patents
Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y un nsaidInfo
- Publication number
- PE20110305A1 PE20110305A1 PE2011000207A PE2011000207A PE20110305A1 PE 20110305 A1 PE20110305 A1 PE 20110305A1 PE 2011000207 A PE2011000207 A PE 2011000207A PE 2011000207 A PE2011000207 A PE 2011000207A PE 20110305 A1 PE20110305 A1 PE 20110305A1
- Authority
- PE
- Peru
- Prior art keywords
- dimethylaminomethyl
- diol
- cyclohexane
- methoxy
- phenyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
REFERIDA A UNA COMBINACION FARMACEUTICA QUE COMPRENDE: a) UN COMPONENTE 6-DIMETILAMINOMETIL-1-(3-METOXI-FENIL)-CICLOHEXANO-1,3-DIOL Y b) UN FARMACO ANTIINFLAMATORIO NO ESTEROIDEO (NSAID) TAL COMO ACIDO ACETILSALICILICO, DICLOFENACO, DIFLUNISAL, FLURBIPROFENO, KETOROLACO, ENTRE OTROS; DONDE EL COMPONENTE a) ES (1RS,3RS,6RS)-6-DIMETILAMINOMETIL-1-(3-METOXI-FENIL)-CICLOHEXANO-1,3-DIOL O UNA SAL DEL MISMO, SIENDO PREFERIDAS LA SAL CLORHIDRATO O SAL DE ACIDO FOSOFORICO. DICHA COMBINACION ES UTIL EN EL TRATAMIENTO DEL DOLOR Y OSTEOARTRITIS
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08015687 | 2008-09-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20110305A1 true PE20110305A1 (es) | 2011-06-15 |
Family
ID=40342095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2011000207A PE20110305A1 (es) | 2008-09-05 | 2009-09-04 | Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y un nsaid |
Country Status (18)
Country | Link |
---|---|
US (1) | US20100063009A1 (es) |
EP (1) | EP2331102A1 (es) |
JP (1) | JP2012501987A (es) |
KR (1) | KR20110065488A (es) |
CN (1) | CN102186480A (es) |
AR (1) | AR073495A1 (es) |
AU (1) | AU2009289736A1 (es) |
BR (1) | BRPI0918919A2 (es) |
CA (1) | CA2735139A1 (es) |
CL (1) | CL2011000388A1 (es) |
CO (1) | CO6341550A2 (es) |
EC (1) | ECSP11010875A (es) |
IL (1) | IL211348A0 (es) |
MX (1) | MX2011002117A (es) |
PE (1) | PE20110305A1 (es) |
RU (1) | RU2011112445A (es) |
WO (1) | WO2010025934A1 (es) |
ZA (1) | ZA201101668B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9308196B2 (en) * | 2012-05-18 | 2016-04-12 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1 r,4r) -6'-fluoro-N ,N-dimethyl-4-phenyl-4',9'-d ihydro-3'H-spiro[cyclohexane-1,1'-pyrano-[3,4,b]indol]-4-amine and an oxicam |
US9320729B2 (en) | 2012-05-18 | 2016-04-26 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-flouro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a propionic acid derivative |
US20130310385A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4,b]indol]-4-amine and Antidepressants |
US8912226B2 (en) * | 2012-05-18 | 2014-12-16 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r) -6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a NSAR |
US9855286B2 (en) * | 2012-05-18 | 2018-01-02 | Gruenenthal Gmbh | Pharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-di methyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano-[3,4,b]indol]-4-amine and a salicylic acid component |
US20130310435A1 (en) | 2012-05-18 | 2013-11-21 | Gruenenthal Gmbh | Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5516803A (en) * | 1991-10-30 | 1996-05-14 | Mcneilab, Inc. | Composition comprising a tramadol material and a non-steroidal anti-inflammatory drug |
DE19525137C2 (de) * | 1995-07-11 | 2003-02-27 | Gruenenthal Gmbh | 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe |
JP2002538176A (ja) * | 1999-03-01 | 2002-11-12 | オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド | トラマドール物質および選択的cox−2阻害薬を含んで成る組成物 |
AU2003264311A1 (en) * | 2002-08-28 | 2004-04-08 | Jin Wang | Oral formulations of ibuprofen and tramadol, methods and preparation thereof |
HUE033042T2 (en) * | 2002-11-22 | 2017-11-28 | Gruenenthal Gmbh | Combination of selected analgesics with COX II inhibitors |
US20060142288A1 (en) * | 2004-12-07 | 2006-06-29 | Stephen Peroutka | Combinations and methods for headaches |
-
2009
- 2009-09-04 MX MX2011002117A patent/MX2011002117A/es not_active Application Discontinuation
- 2009-09-04 WO PCT/EP2009/006439 patent/WO2010025934A1/en active Application Filing
- 2009-09-04 CN CN2009801347882A patent/CN102186480A/zh active Pending
- 2009-09-04 US US12/554,243 patent/US20100063009A1/en not_active Abandoned
- 2009-09-04 CA CA2735139A patent/CA2735139A1/en not_active Abandoned
- 2009-09-04 PE PE2011000207A patent/PE20110305A1/es not_active Application Discontinuation
- 2009-09-04 KR KR1020117007514A patent/KR20110065488A/ko not_active Application Discontinuation
- 2009-09-04 RU RU2011112445/15A patent/RU2011112445A/ru unknown
- 2009-09-04 AR ARP090103404A patent/AR073495A1/es unknown
- 2009-09-04 BR BRPI0918919A patent/BRPI0918919A2/pt not_active Application Discontinuation
- 2009-09-04 JP JP2011525467A patent/JP2012501987A/ja not_active Withdrawn
- 2009-09-04 AU AU2009289736A patent/AU2009289736A1/en not_active Abandoned
- 2009-09-04 EP EP09811079A patent/EP2331102A1/en not_active Withdrawn
-
2011
- 2011-02-22 IL IL211348A patent/IL211348A0/en unknown
- 2011-02-22 CO CO11021391A patent/CO6341550A2/es not_active Application Discontinuation
- 2011-02-23 CL CL2011000388A patent/CL2011000388A1/es unknown
- 2011-03-03 ZA ZA2011/01668A patent/ZA201101668B/en unknown
- 2011-03-04 EC EC2011010875A patent/ECSP11010875A/es unknown
Also Published As
Publication number | Publication date |
---|---|
RU2011112445A (ru) | 2012-10-10 |
CA2735139A1 (en) | 2010-03-11 |
EP2331102A1 (en) | 2011-06-15 |
MX2011002117A (es) | 2011-03-28 |
WO2010025934A1 (en) | 2010-03-11 |
BRPI0918919A2 (pt) | 2015-12-01 |
JP2012501987A (ja) | 2012-01-26 |
ECSP11010875A (es) | 2011-04-29 |
CO6341550A2 (es) | 2011-11-21 |
US20100063009A1 (en) | 2010-03-11 |
AR073495A1 (es) | 2010-11-10 |
AU2009289736A1 (en) | 2010-03-11 |
KR20110065488A (ko) | 2011-06-15 |
IL211348A0 (en) | 2011-05-31 |
CL2011000388A1 (es) | 2011-06-17 |
ZA201101668B (en) | 2011-11-30 |
CN102186480A (zh) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2019000056A1 (es) | Sales y formas cristalinas del ácido 2-(3r,5r,6s)-5-(3-clorofenil)-6-(4-clorofenil)-1-(s)-1(isopropilsufonil)-3-metilbutan-2-il)-3-metil-2-oxopiperidin-3-il)acético; proceso de preparación de una de las sales; composición farmacéutica que comprende; útiles para tratar cáncer. (solicitud divisional 201503589) | |
CL2012000026A1 (es) | Formulación farmacéutica acuosa que contiene una insulina, un análogo de insulina o un derivado insulínico, o una de sus sales farmacológicamente tolerables, y metionina; proceso para preparar dicha formulación; medicamento que la contiene; y su uso para tratar la diabetes mellitus. | |
PE20110305A1 (es) | Combinacion farmaceutica que contiene el 6-dimetilaminometil-1-(3-metoxi-fenil)-ciclohexano-1,3-diol y un nsaid | |
CL2013000063A1 (es) | Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion. | |
CO6351742A2 (es) | Compuestos organicos para la cicatrizacion de heridas | |
EA201001577A1 (ru) | Ингибитор дпп-4 в комбинации с дополнительным противодиабетическим агентом, таблетки, включающие указанные композиции, их применение и способ их получения | |
DOP2016000253A (es) | Nuevos compuestos | |
CL2008002999A1 (es) | Uso de una composicion farmeceutica que comprende trns-clominefo para preparar un medicamenteo util en el ratamiento de recuccion de los niveles de glucosa en ayunas en un varon. | |
CO6781465A2 (es) | Composición farmacéutica, métodos de tratamiento y usos de la misma | |
BRPI0908421B8 (pt) | solução estável de um composto farmacêutico | |
CO6511249A2 (es) | Composiciones que comprenden tramadol y celecoxib en el tratamiento del dolor | |
AR054249A1 (es) | Tratamiento de enfermedades del tejido conectivo de la piel | |
CL2019003259A1 (es) | Compuesto de insulina acilada. | |
ES2673406T3 (es) | Alfa-derivados de ácidos grasos cis-monoinsaturados para uso como medicamentos en el tratamiento de la diabetes | |
CO6280474A2 (es) | Composicion farmaceutica para el tratamiento de la eyaculacion precoz | |
DOP2016000251A (es) | Inhibidores de las vías de señalización de wnt | |
AR075041A1 (es) | Composicion farmaceutica que contiene aleglitazar, proceso, uso. | |
CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
CL2010001577A1 (es) | Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias. | |
GT200900296A (es) | Composición farmacéutica que comprende la combinación de un agente anti inflamatorio no esteroideo y un agente anticonvulsivante. | |
CL2008001282A1 (es) | Composicion farmaceutica con actividad antimicrobiana que comprende un aminoacidos n halogenado y un agente antiinflamatorio; uso para prevenir o tratar una infeccion de tejidos, donde dicho tejido es ocular, nasal, seno nasal o dermico o una infeccion respiratoria. | |
EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
CL2010001594A1 (es) | Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida. | |
PE20121537A1 (es) | Combinacion de teobromina con un descongestivo | |
CL2011000387A1 (es) | Combinacion que comprende a) 6-dimetilaminometil-1-(3-metoxifenil)-ciclohexano-1,3-diol y b) paracetamol; forma de dosificacion; uso para tratar osteoartritis y dolor. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |